NCI Cancer Bulletin for April 3, 2012

April 3, 2012 • Volume 9 / Number 7

Read the NCI Cancer Bulletin

The latest issue of the NCI Cancer Bulletin is now available at http://www.cancer.gov/ncicancerbulletin. Keep up to date on the latest research and advances in the prevention, treatment, and understanding of cancer.

News

Read This Issue


  • Featured Article: Targeted Drug Shows Promise in Common Form of Lymphoma »
  • Drawbacks of Adding MRI to Mammography Plus Ultrasound May Outweigh Benefits »
  • Ultrasound-Guided Breast-Conserving Surgery May Reduce Need for Further Surgeries »
  • Anal HPV Infections and Precancerous Lesions Are Common in Men Who Have Sex with Men »
  • Olaparib Delays Progression of Ovarian Cancer after Initial Treatment »
  • Transplant Recipients at Higher Risk of Aggressive Form of Lymphoma »
  • Some Melanoma Cells May Use the Body's Immune Response to Escape Destruction »
  • Also in the Journals: Methylation Levels in HPV DNA May Indicate Risk for Cervical Precancer »

Commentary

Read This Issue


  • A Conversation with Dr. Bert Vogelstein about Whole-Genome Sequencing to Predict
    Cancer Risk »

In Depth

Read This Issue


  • U.S. Cancer Deaths Continue Steady Decline »
  • Drugs Target Epigenetic Changes to Reprogram Cancer Cells »
  • Featured Clinical Trial: Virus Therapy for Extensive-Stage Small Cell Lung Cancer »

Updates

Read This Issue

  • Legislative Update »
  • FDA Update »
  • Notes »

 

Do you know someone who would enjoy receiving the NCI Cancer Bulletin? To send a copy of the latest issue to a colleague, visit www.cancer.gov/ncicancerbulletin. The NCI Cancer Bulletin will be sent to you biweekly unless you unsubscribe. To unsubscribe, send a blank email to nci-bulletin-signoff-request@list.nih.gov.   

 

No comments:

Post a Comment